[1]
Kumar, M.P.tran. 2024. THE EFFICACY AND SAFETY OF LEBRIKIZUMAB PLUS TOPICAL CORTICOSTEDOIDS IN MODERATETO SEVERE ATOPIC DERMATITIS. Cuestiones de Fisioterapia. 53, 03 (Dec. 2024), 6987–6993. DOI:https://doi.org/10.48047/vwmbcr61.